Seracare Webinar: The promise of Liquid Biopsy for cancer diagnostics and therapeutic monitoring: are we there yet?

    Activity: Talk and presentation › Academic presentation › Academic

    Description

    “Detection of clinical-relevant mutations in NSCLC eligible for targeted therapy using circulating tumor DNA in cell free plasma”
    Period27-Oct-2020
    Event titleSeracare Webinar: The promise of Liquid Biopsy for cancer diagnostics and therapeutic monitoring: are we there yet?
    Event typeConference
    Degree of RecognitionInternational